WednesdayJun 18, 2025 9:10 am

QualityStocksNewsBreaks – GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced it has finalized a Share Exchange Agreement to acquire 100% of Charter House Financial AU, with the transaction set to close by July 13, 2025. The acquisition marks a shift in GivBux's strategic focus toward gold-backed financial services, leveraging Charter House’s asset-backed infrastructure and global networks. The companies plan to integrate operations and jointly develop offerings that fuse precious metals with digital payments through the GivBux app. Charter House founder Anthony Capazze, a 25-year veteran in gold markets and finance, projected potential revenue of up to $200…

Continue Reading

WednesdayJun 18, 2025 9:00 am

Solowin Holdings (NASDAQ: SWIN) Is ‘One to Watch’

Solowin Holdings offers diversified exposure to both traditional financial services and next-generation digital assets. The company leverages regulatory licenses in Hong Kong to serve global high-net-worth and institutional investors. Solowin delivers brokerage, investment banking, asset management, and Web3 services across its Solomon Win and Solomon VA+ platforms, offering clients seamless access to both traditional and digital financial solutions. Strategic investments, such as its $10M contribution to AlloyX, an Asia-based stablecoin infrastructure firm, highlight Solowin’s proactive role in fintech innovation. Led by seasoned executives with decades of capital markets experience, the company is positioned for sustained global expansion. Solowin (NASDAQ: SWIN) is…

Continue Reading

WednesdayJun 18, 2025 9:00 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf brand, announced that PGA TOUR Champions star Miguel Ángel Jiménez has officially joined the company and will play its Newton Fast Motion shaft, which he used to win the Principal Charity Classic. Jiménez’s playoff win in Iowa marked his 16th PGA TOUR Champions title and the second Tour victory for Newton’s Motion shaft line. The Fast Motion shaft, launched in April 2025, features advanced carbon fiber construction and proprietary performance technologies aimed at delivering speed, control, and consistency for golfers with moderate swing speeds. The win further validates Newton’s impact across professional…

Continue Reading

TuesdayJun 17, 2025 10:30 am

Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women’s Golf Boom

Women make up roughly 28% of on-course golfers in the United States, a historic high. The global golf equipment market is booming, generating an estimated $25.5 billion in 2024 and projected to grow at nearly 6% annually. Newton Golf’s lighter shaft is engineered to weigh less than previous versions while maintaining precision, stability and distance. A surge in women’s golf participation is reshaping the industry, drawing fresh energy and opportunity to equipment manufacturers. Newton Golf Company (NASDAQ: NWTG) recently released the perfect piece of equipment for this dynamic market — a lighter shaft option, designed to deliver premium performance for golfers…

Continue Reading

TuesdayJun 17, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease

Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and Japan. Even with treatment, symptoms can continue occurring for many patients and significantly affect their quality of life and productivity. Soligenix has initiated a clinical trial to evaluate the safety, tolerability and preliminary efficacy of SGX945 in patients suffering from oral ulcers. Behçet’s disease is a rare, chronic autoimmune disorder characterized by inflammation of blood vessels, leading to a range of symptoms including painful mouth and genital ulcers, eye inflammation and skin lesions. With limited treatment options available, Soligenix (NASDAQ: SNGX) is at the forefront of…

Continue Reading

TuesdayJun 17, 2025 9:10 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries and an FDA application under review, Intelligent Bio Solutions is targeting U.S. market entry in the second half of 2025 and expects to scale through distributor partnerships and targeted marketing. To view the full article, visit https://ibn.fm/HZpfg About Intelligent Bio Solutions Inc. Intelligent Bio Solutions…

Continue Reading

TuesdayJun 17, 2025 9:00 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Is ‘One to Watch’

LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million. The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces. Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt. LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports…

Continue Reading

TuesdayJun 17, 2025 9:00 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with automated arrhythmia insights Combined platform aims to improve cardiac care access and speed time to diagnosis HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with AccurKardia, a leader in automated ECG diagnostics, to integrate its FDA-cleared AccurECG(TM) software into HeartBeam’s cable-free, credit card-sized 3D ECG device. The partnership unites two innovators in ambulatory cardiac monitoring to create a more scalable, accessible solution for arrhythmia detection and management. HeartBeam’s device captures electrical signals in three non-coplanar directions and synthesizes them into a 12-lead ECG for remote use.…

Continue Reading

MondayJun 16, 2025 12:45 pm

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Poised to Capitalize on Rising Platinum, Palladium Prices Amid Renewed Demand

Platinum prices have recently reached their highest levels in more than two years. Palladium has also seen renewed interest as industrial demand stabilizes and inflation pressures persist. Platinum Group Metals Ltd. stands out due to its advanced-stage project, strong partnerships and commitment to innovation. In recent weeks, platinum and palladium prices have gained considerable momentum, driven largely by a resurgence in demand from China’s jewelry sector and increasing concern over global supply constraints. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development-stage mining company focused exclusively on platinum group metals (“PGMs”), is well positioned to capitalize on these favorable…

Continue Reading

MondayJun 16, 2025 12:00 pm

HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam has developed the first cable-free system capable of synthesizing a 12-lead ECG from 3D, non-coplanar electrical signals captured in real time. Patients can have the HeartBeam System with them at all times, ready to record an ECG in 30 seconds at home or anywhere when they feel symptoms to reduce delays in care. The HeartBeam System is now FDA cleared for arrhythmia assessment, with additional FDA review underway for its 12-lead ECG synthesis software for the same indication. A recent partnership with AccurKardia enhances HeartBeam’s arrhythmia solution with an FDA-cleared automated rhythm interpretation software. HeartBeam holds 20 issued patents,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered